Semax
Nootropic research heptapeptide
Buy Semax in Australia for nootropic research. Lab-verified, lyophilised, Australian-shipped.
Research Use Only. This compound is sold strictly for in-vitro research and laboratory purposes and is not intended for human consumption or therapeutic use. By purchasing you confirm you are a qualified researcher and agree to our full disclaimer.
Synthetic analogue of ACTH(4-10) studied for nootropic and neuroprotective research applications.
Semax is a synthetic heptapeptide originally developed at the Russian Academy of Sciences and based on a fragment of adrenocorticotropic hormone (ACTH 4-10). It is one of the most studied nootropic research peptides in Russian and Eastern European literature, with published work covering models of cognitive performance, attention, neuroprotection, and stroke recovery. Quantum Labs supplies Semax as a lyophilised powder for Australian research applications.
Semax research typically uses intranasal delivery — the peptide is well-absorbed across the nasal mucosa and crosses the blood-brain barrier in pre-clinical models. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
Research Mechanism
Research suggests modulation of BDNF and monoaminergic systems associated with cognitive markers in study populations.
HPLC verified against a ≥99% purity specification. Independently tested by accredited third-party laboratories.
Semax — frequently asked questions
What is Semax?
Semax is a synthetic heptapeptide based on the 4-10 fragment of adrenocorticotropic hormone (ACTH). It is studied in nootropic and neuroprotective research, with published work covering cognitive performance, attention, and stroke-recovery models.
Is Semax legal in Australia?
Semax is restricted for compounded human therapeutic supply in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies Semax for research use only.
What is the typical Semax research dosage?
Published Russian clinical research has used intranasal Semax doses in wide ranges depending on the model — typically 0.1 mg to 1.5 mg per intranasal application. Human therapeutic dosing in Australia is not established. Researchers should consult primary literature for protocol-specific guidance.
How is Semax administered in research?
Semax is most often delivered intranasally because the peptide is well-absorbed across the nasal mucosa and reaches the central nervous system through olfactory-pathway transport. Reconstituted Semax can be delivered via nasal spray bottles or precision droppers in research applications.
What is the difference between Semax and Selank?
Semax is a fragment of ACTH studied for nootropic and neuroprotective effects. Selank is a fragment of tuftsin studied for anxiolytic effects. Both originated in Russian peptide research; both use intranasal delivery in research designs. They target different receptor systems and are often the subject of complementary research protocols.
What are the documented Semax side effects?
Russian clinical research has reported a favourable tolerability profile across the dose ranges studied. Long-term safety data is limited to the corpus of Russian and Eastern European literature. Quantum Labs supplies this compound for laboratory and pre-clinical research use only. It is not represented for human therapeutic use, and questions about clinical dosing, treatment effects, or personal use should be directed to a qualified medical practitioner.
Researchers also explore
DSIP
Lyophilised powderDelta sleep-inducing peptide
Temporarily unavailable. Leave your email and we'll let you know the moment it's back in stock.
View details →
Selank
Nasal sprayAnxiolytic research peptide
Temporarily unavailable. Leave your email and we'll let you know the moment it's back in stock.
View details →
NAD+
Lyophilised powderCellular redox cofactor
Temporarily unavailable. Leave your email and we'll let you know the moment it's back in stock.
View details →